Medicaid Expansion Enhances Long-Term Survival Rates in Cancer Patients

Recent studies show that Medicaid expansion under the ACA significantly improves long-term survival rates in cancer patients, especially in vulnerable populations. This evidence supports policy efforts to expand healthcare access and improve cancer outcomes.
In a significant development, recent research indicates that Medicaid expansion has a positive impact on the long-term survival of individuals diagnosed with cancer. The study, published in the journal Cancer Discovery, analyzed data from over 1.4 million adult cancer cases across North America, comparing survival outcomes from before and after many states adopted Medicaid expansion under the Affordable Care Act (ACA).
Medicaid expansion, initiated in 2014, allowed states to extend eligibility to adults earning up to 138% of the federal poverty level. This policy change has already been associated with increased insurance coverage, easier access to cancer screening services, and improved short-term survival rates. However, its influence on longer-term outcomes, such as five-year survival among cancer patients, was previously less understood.
Using a difference-in-differences approach, researchers examined data from 26 states that adopted Medicaid expansion and compared it with 12 non-expansion states during 2007–2008 and 2014–2015. The analysis revealed that Medicaid expansion was linked to notable improvements in survival rates, especially among vulnerable populations such as those living in rural and high-poverty areas. Specifically, cancer patients in expansion states experienced an increase of 2.55 percentage points in cause-specific survival and 3.03 points in overall survival. Additionally, non-Hispanic Black individuals saw a survival improvement with a difference of 1.05 points, while non-Hispanic Whites experienced increases of 0.37 and 0.57 points in cause-specific and overall survival, respectively.
The findings underscore the importance of Medicaid expansion in prolonging the lives of cancer patients, emphasizing the need for policymakers to maintain or extend such programs. The research also highlights that broader access to health coverage can lead to better early detection, treatment, and long-term outcomes in cancer care.
Limitations of the study include potential confounding factors such as increased insurance coverage across the board due to the ACA and exclusions of individuals lacking complete sociodemographic data. Nonetheless, the evidence presented advocates strongly for ongoing efforts to expand Medicaid in states that have yet to adopt these policies, aiming to improve cancer survival outcomes nationwide.
This research is part of ongoing efforts to evaluate healthcare policies' effects on cancer outcomes and is accessible through Cancer Discovery, DOI: 10.1158/2159-8290.CD-25-1244. It was conducted with the support of the American Association for Cancer Research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Study Finds Mediterranean and Keto Diets Effectively Lower Blood Pressure and Promote Weight Loss
Discover how recent research shows both Mediterranean and keto diets can effectively lower blood pressure and promote weight loss, offering personalized options for cardiovascular health management.
Significant Decline in US Overdose Deaths Marks Record One-Year Drop in 2024
US overdose deaths saw a historic 27% decline in 2024, the largest single-year drop in decades, highlighting progress in combating the overdose epidemic.
Early Detection and Advances in Uveitis Treatment to Prevent Vision Loss
Early detection and innovative treatments are crucial to managing uveitis, a leading cause of vision loss worldwide. New guidelines emphasize prompt diagnosis and personalized care to prevent irreversible eye damage.
Research Finds Harmful Chemical Created by Vaping Cannabinoid Mixtures That Can Damage Human Tissue
A new study reveals that vaping cannabinoid mixtures can produce a toxic chemical that destroys human tissue, highlighting health risks associated with vaping CBD and other cannabinoids.



